(Q67898485)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826431%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Suramin and tumor cell radiosensitivity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826431%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Suramin and tumour cell radiosensitivity (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

3 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

3 December 2022

author name string

J. T. Leith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826431

3 December 2022

S. Michelson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826431

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1826431

3 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826431%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:027753799190074N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

https://api.elsevier.com/content/article/PII:027753799190074N?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

European Journal of Cancer

3 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826431%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826431%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826431%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826431%20AND%20SRC:MED&resulttype=core&format=json

Suramin: an anticancer drug with a unique mechanism of action.

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

Suramin: a new therapeutic concept

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

Lack of response to suramin in patients with AIDS and AIDS-related complex

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

Enhancement of sensitivity of human squamous carcinoma cells to radiation by epidermal growth factor

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90074-N

3 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826431%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference